Lake Street Advisors Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Lake Street Advisors Group’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,300	Closed	-$97K	–	356
2021 Q1	$97K	Sell	1,300 -100	-7%	-$10.4K	0.01%	326
2020 Q4	$152K	Buy	+1,400	New	+$128K	0.01%	303

Other funds holding SYRS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Lake Street Advisors Group's SYRS Position: Q2 2021 in Review

Lake Street Advisors Group sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2021, closing a stake of 1,300 shares — an estimated $97K sold.

Lake Street Advisors Group first reported a position in SYRS in Q4 2020 and held it in 2 quarters. The position peaked at $152K in Q4 2020. 100 funds tracked by Wall St. Rank hold SYRS as of Q2 2021.

Lake Street Advisors Group reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Lake Street Advisors Group sold 1,300 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $97K.
Lake Street Advisors Group first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
Lake Street Advisors Group's Syros Pharmaceuticals, Inc. Common Stock position peaked at $152K in Q4 2020.
100 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Lake Street Advisors Group's 13F filing for Q2 2021, filed 13 Aug 2021.